ZURICH (Reuters) - Swiss contract drug manufacturer Lonza Group on Friday named Roche executive Pierre-Alain Ruffieux as its new chief executive effective from Nov. 1.Ruffieux is now head of global pharma technical operations at Roche , Lonza said in a statement. Before that he was a manager at Novartis and has over 20 years experience in biopharmaceuticals.